Skip to main content
. 2018 Jun 6;15(6):875–879. doi: 10.1111/iwj.12939

Table 4.

Topical therapy

No. of patients (%)
Monotherapy 40/64
Polytherapy 21/64
None 3/64
Steroids 35 (54.7%)
Advanced dressings 23 (35.9%)
Antiseptic agents 16 (25%)
Topical antibiotics 15 (23.4%)
TCI 3 (4.7%)
Other topical products 15 (23.4%)

TCI, topical calcineurin inhibitors.